TEV-50717

· Teva Branded Pharmaceutical Products R&D, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TEV-50717, covering 2020-06-09 to 2024-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Test if TEV-50717 is Safe and Effective in Relieving Abnormal Involuntary Movements in Cerebral Palsy [Phase 3]

See pricing